(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 9.37% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Inspire Medical Systems's revenue in 2025 is $882,622,000.On average, 22 Wall Street analysts forecast INSP's revenue for 2025 to be $26,818,507,453, with the lowest INSP revenue forecast at $25,627,774,788, and the highest INSP revenue forecast at $27,720,709,729. On average, 22 Wall Street analysts forecast INSP's revenue for 2026 to be $29,986,239,888, with the lowest INSP revenue forecast at $28,361,404,099, and the highest INSP revenue forecast at $32,630,375,382.
In 2027, INSP is forecast to generate $33,647,350,572 in revenue, with the lowest revenue forecast at $31,003,215,078 and the highest revenue forecast at $38,499,775,050.